Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague Model

Plague is a zoonotic disease that is caused by <i>Yersinia pestis</i>. Monoclonal antibodies (mAbs) that bind to the V-antigen, a virulence factor that is produced by <i>Y. pestis</i>, can passively protect mice from plague. An analysis of protective mAbs that bind to V-antig...

Full description

Bibliographic Details
Main Authors: Kei Amemiya, Jennifer L. Dankmeyer, Sarah L. Keasey, Sylvia R. Trevino, Michael M. Wormald, Stephanie A. Halasohoris, Wilson J. Ribot, David P. Fetterer, Christopher K. Cote, Patricia L. Worsham, Jeffrey J. Adamovicz, Robert G. Ulrich
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Antibodies
Subjects:
Online Access:https://www.mdpi.com/2073-4468/9/3/37
_version_ 1797560469137915904
author Kei Amemiya
Jennifer L. Dankmeyer
Sarah L. Keasey
Sylvia R. Trevino
Michael M. Wormald
Stephanie A. Halasohoris
Wilson J. Ribot
David P. Fetterer
Christopher K. Cote
Patricia L. Worsham
Jeffrey J. Adamovicz
Robert G. Ulrich
author_facet Kei Amemiya
Jennifer L. Dankmeyer
Sarah L. Keasey
Sylvia R. Trevino
Michael M. Wormald
Stephanie A. Halasohoris
Wilson J. Ribot
David P. Fetterer
Christopher K. Cote
Patricia L. Worsham
Jeffrey J. Adamovicz
Robert G. Ulrich
author_sort Kei Amemiya
collection DOAJ
description Plague is a zoonotic disease that is caused by <i>Yersinia pestis</i>. Monoclonal antibodies (mAbs) that bind to the V-antigen, a virulence factor that is produced by <i>Y. pestis</i>, can passively protect mice from plague. An analysis of protective mAbs that bind to V-antigen was made to assess binding sites, avidities, and affinities. Anti-V mAbs were screened for their efficacy in a murine model of plague. Antigen-binding sites of protective V mAbs were determined with a linear peptide library, V-antigen fragment, competitive binding, and surface plasmon resonance. The avidities to the V-antigen was determined by ELISA, and affinities of the mAbs to the V-antigen were determined by surface plasmon resonance. The most protective mAb 7.3 bound to a unique conformational site on the V-antigen, while a less protective mAb bound to a different conformational site located on the same V-antigen fragment as mAb 7.3. The avidity of mAb 7.3 for the V-antigen was neither the strongest overall nor did it have the highest affinity for the V-antigen. The binding site of the most protective mAb was critical in its ability to protect against a lethal plague challenge.
first_indexed 2024-03-10T18:00:59Z
format Article
id doaj.art-673628452d76476886124e3319433074
institution Directory Open Access Journal
issn 2073-4468
language English
last_indexed 2024-03-10T18:00:59Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Antibodies
spelling doaj.art-673628452d76476886124e33194330742023-11-20T08:52:33ZengMDPI AGAntibodies2073-44682020-08-01933710.3390/antib9030037Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague ModelKei Amemiya0Jennifer L. Dankmeyer1Sarah L. Keasey2Sylvia R. Trevino3Michael M. Wormald4Stephanie A. Halasohoris5Wilson J. Ribot6David P. Fetterer7Christopher K. Cote8Patricia L. Worsham9Jeffrey J. Adamovicz10Robert G. Ulrich11Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USAMolecular and Translational Sciences, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USABacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USAMolecular and Translational Sciences, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USAPlague is a zoonotic disease that is caused by <i>Yersinia pestis</i>. Monoclonal antibodies (mAbs) that bind to the V-antigen, a virulence factor that is produced by <i>Y. pestis</i>, can passively protect mice from plague. An analysis of protective mAbs that bind to V-antigen was made to assess binding sites, avidities, and affinities. Anti-V mAbs were screened for their efficacy in a murine model of plague. Antigen-binding sites of protective V mAbs were determined with a linear peptide library, V-antigen fragment, competitive binding, and surface plasmon resonance. The avidities to the V-antigen was determined by ELISA, and affinities of the mAbs to the V-antigen were determined by surface plasmon resonance. The most protective mAb 7.3 bound to a unique conformational site on the V-antigen, while a less protective mAb bound to a different conformational site located on the same V-antigen fragment as mAb 7.3. The avidity of mAb 7.3 for the V-antigen was neither the strongest overall nor did it have the highest affinity for the V-antigen. The binding site of the most protective mAb was critical in its ability to protect against a lethal plague challenge.https://www.mdpi.com/2073-4468/9/3/37monoclonal antibodies<i>Yersinia pestis</i>plaguebinding sitesaviditiesaffinities
spellingShingle Kei Amemiya
Jennifer L. Dankmeyer
Sarah L. Keasey
Sylvia R. Trevino
Michael M. Wormald
Stephanie A. Halasohoris
Wilson J. Ribot
David P. Fetterer
Christopher K. Cote
Patricia L. Worsham
Jeffrey J. Adamovicz
Robert G. Ulrich
Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague Model
Antibodies
monoclonal antibodies
<i>Yersinia pestis</i>
plague
binding sites
avidities
affinities
title Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague Model
title_full Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague Model
title_fullStr Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague Model
title_full_unstemmed Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague Model
title_short Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against <i>Yersinia pestis</i> Infection in a Bubonic Plague Model
title_sort binding sites of anti lcr v monoclonal antibodies are more critical than the avidities and affinities for passive protection against i yersinia pestis i infection in a bubonic plague model
topic monoclonal antibodies
<i>Yersinia pestis</i>
plague
binding sites
avidities
affinities
url https://www.mdpi.com/2073-4468/9/3/37
work_keys_str_mv AT keiamemiya bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT jenniferldankmeyer bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT sarahlkeasey bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT sylviartrevino bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT michaelmwormald bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT stephanieahalasohoris bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT wilsonjribot bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT davidpfetterer bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT christopherkcote bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT patricialworsham bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT jeffreyjadamovicz bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel
AT robertgulrich bindingsitesofantilcrvmonoclonalantibodiesaremorecriticalthantheaviditiesandaffinitiesforpassiveprotectionagainstiyersiniapestisiinfectioninabubonicplaguemodel